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Introduction
Case definitions form an important part of standardized sys-
tems for public health surveillance. They can be used in the 
reporting of the conditions under surveillance, the monitoring 
of geographical and temporal variations in prevalence, the 
detection of the increases in incidence that may be indicative 
of outbreaks and the evaluation of the effectiveness of control 
and response efforts. By permitting valid comparisons across 
time and between data from different locations, the use of 
standard case definitions can improve the usefulness of data 
generated by a surveillance system.1 In general, case definitions 
for infectious diseases need to be concise and uncomplicated 
if they are to be useful for, and useable by, all the health-care 
providers, laboratory staff and public health personnel in-
volved in case reporting.
The usefulness of a case definition depends on the char-
acteristics of the condition of interest, the characteristics of 
other conditions with which the condition of interest may be 
confused and the objectives of any surveillance on the condi-
tion of interest. Ideally, a case definition would be based on 
a combination of signs, symptoms and results of laboratory 
tests that uniquely characterizes the condition of interest. 
The definition would also be easily applicable. Unfortunately, 
ease of use tends to decrease as specificity increases and there 
often needs to be a trade-off between the sensitivity of a case 
definition and its specificity. The importance of a definition’s 
specificity, relative to its sensitivity, depends on the definition’s 
intended use. For example, sensitivity may be particularly 
important in evaluating the size of an outbreak, when the 
number of missed cases needs to be minimized. In research, 
however, it may be more important to minimize the number 
of false positives enrolled by using a case definition that is 
particularly specific.
Although a fixed case definition can facilitate valid com-
parisons of disease occurrence over long time periods, case 
definitions may often be revised to improve their sensitivity 
and/or specificity.1 The relative values of the clinical, epidemio-
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logical and/or laboratory criteria used 
for case definitions may change over 
time. For example, an emerging new 
pathogen could prompt multiple revi-
sions of a case definition.2,3 Further, case 
definitions have also been modified to 
enhance their sensitivity across a wider 
age range of individuals4 or to make use 
of novel diagnostic tests that improve 
the detection of the disease-causing 
pathogen.5,6 In other instances, the lan-
guage used in a case definition has been 
simplified and/or an attempt has been 
made to reduce multiple definitions for 
the same condition to a single global 
one.7 The case definitions for infection 
with the human immunodeficiency 
virus and acquired immunodeficiency 
syndrome were revised multiple times 
between 1982 and 2014, to reflect new 
knowledge about the syndrome and 
the isolation of the virus and to include 
laboratory testing.8
In the revision of any case definition 
there needs to be careful deliberation 
over how the available relevant evidence 
can help balance the sensitivity and 
specificity of the definition in such a 
way that the objectives of any related 
surveillance can be met. In 2011, the 
World Health Organization (WHO) 
launched an initiative to develop global 
standards for influenza surveillance, in-
cluding a global case definition of severe 
influenza. This initiative was, in part, a 
response to the 2009–2010 H1N1 influ-
enza pandemic. Below, as an illustration 
of case definition revision, we discuss 
the process followed in revising WHO’s 
case definitions for both influenza-like 
illness (ILI) and severe acute respiratory 
infection (SARI).
Impetus for change
Since 1999, WHO has recommended 
a case definition for ILI that can be 
used for public health surveillance, to 
monitor the seasonal variations of in-
fluenza activity and to identify the best 
patients to be included in virological 
surveillance.9 The 2009–2010 H1N1 
pandemic, however, prompted the 
further evaluation of the objectives of 
influenza surveillance in and after 2010 
and the examination of whether the 
case definitions existing in 2010 could 
be improved to strengthen the useful-
ness of the surveillance framework and 
pandemic-preparedness efforts. The ap-
pearance of human infections with novel 
influenza viruses further supported the 
need to monitor severe influenza-related 
diseases and understand influenza-asso-
ciated disease severity and burden more 
fully. Prior to the 2009–2010 pandemic, 
no global standard for SARI had been 
developed for wide implementation. The 
lack of standardization in case defini-
tions and lack of a systematic approach 
to the surveillance of mild and severe 
influenza greatly hampered efforts to 
monitor and understand the burden and 
severity of the 2009–2010 pandemic in 
the global context.
A global standardized case defini-
tion for influenza is essential if we are 
to make valid comparisons of surveil-
lance data collected in different areas of 
the world. To be very useful in surveil-
lance, an ILI case definition needs to 
be based on simple criteria, yet have 
levels of sensitivity and specificity that 
permit accurate estimates of influenza 
disease burden and permit influenza 
to be distinguished from other respira-
tory illnesses.10 The largest challenge 
for influenza surveillance is that the 
symptoms of influenza are nonspecific.
A conclusion of several evaluations 
of the specificity of WHO’s 1999 clinical 
case definition for influenza was that 
the definition needed to be revised to 
enhance its specificity for influenza de-
tection.11–14 In 2010, only 31 of the 105 
countries that participated in a WHO 
survey of national influenza centres re-
ported using this definition.15 An earlier 
investigation of influenza surveillance 
across western Europe had revealed 
that case definitions varied between 
countries.16
In a global consultation in 2011, 
WHO outlined how influenza surveil-
lance should allow influenza seasonal-
ity to be evaluated in each country and 
allow the start of the influenza season 
to be announced. Surveillance should 
also establish and monitor baseline 
trends in ILI and SARI, so that annual 
changes in severity can be followed and 
provide data that can be used to under-
stand disease burden and the impact of 
influenza in relation to other diseases. In 
addition, it should identify and monitor 
the groups at high risk for severe disease, 
so that priorities for the use of resources 
can be set.17 WHO specified that influ-
enza surveillance should also be used to 
provide virological data and so help in: 
(i) identifying locally circulating types 
and subtypes of influenza viruses and 
their relations to global and regional 
patterns; (ii) describing the antigenic 
character and genetic makeup of circu-
lating influenza viruses; (iii) monitoring 
antiviral sensitivity; (iv) understanding 
the relationship between virus strain 
and severity; (v) providing candidate 
viruses for vaccine production; and 
(vi) providing information for vaccine 
virus selection.17
In the 2011 consultat ion,  to 
strengthen surveillance standards, 
WHO reviewed the relevant evidence 
from research studies and the recom-
mendations of technical experts con-
ducting influenza surveillance. To meet 
WHO’s recommendations, the sensitiv-
ity and specificity of the case definition 
of influenza needed to be high and the 
language used needed to be simple 
enough to remove any ambiguity in the 
interpretation of the criteria.
Process of change
Influenza-like illness
In the guidelines to the 1999 case defi-
nition, clinical influenza was defined as 
“a sudden onset of fever, a temperature 
>38°C and cough or sore throat in the 
absence of another diagnosis”.9 When 
this definition was used, the occurrence 
of ILI in a community generally correlat-
ed with the seasonal levels of transmis-
sion of influenza virus.10 However, the 
sensitivity of the definition was generally 
only about 60% and its specificity ranged 
from 0%, e.g. when there was little circu-
lation of influenza virus, to 60–90%, e.g. 
during each main influenza season and 
the 2009–2010 influenza pandemic.11,12 
In studies conducted before WHO’s 
2011 consultation, the most predictive 
symptoms of influenza were found to be 
cough, fatigue, fever and myalgia.11–14,18,19 
As sore throat had been identified as a 
negative predictor of influenza13,17,19 and 
been found hard to diagnose in young 
children, it was omitted from the clini-
cal case definition of ILI proposed in 
2011.17 The criterion “absence of another 
diagnosis” was also omitted because its 
inclusion in the 1999 definition had 
resulted in the exclusion of ILI cases 
with underlying chronic conditions, e.g. 
asthma and congestive heart failure, that 
can influence influenza risk. The criteri-
on “sudden onset of fever” was changed 
to “acute respiratory illness” in order to 
capture a more general syndrome. A 
time frame was specified to distinguish 
between old and new symptoms and to 
capture acute disease onset. The initial 
proposal was for a time frame of seven 
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days from symptom onset17 but this 
was subsequently revised to 10 days to 
match the time frame for SARI. Finally, 
the measured fever component of the 
definition was changed from “>38°C” 
to “≥ 38°C” to account for the physicians 
and record-keepers who would round 
down slightly higher temperatures to 
38°C. The proposed clinical case defini-
tion of ILI therefore became “an acute 
respiratory illness with a measured 
temperature of ≥ 38 °C and cough, with 
onset within the past 10 days”.
The proposed changes to the ILI 
case definition should result in enhanced 
specificity without greatly compromising 
the definition’s sensitivity (Box 1). These 
changes allow for a better alignment of the 
case definition of ILI with that of SARI. 
They also clarify some aspects of the 
previous ILI case definition that could be 
misinterpreted by health-care providers, in-
cluding those working in sentinel sites and 
national influenza centres and influenza 
epidemiological unit surveillance officers.
Severe acute respiratory infection
Before 2011, a global-surveillance case 
definition of SARI did not exist. Three 
WHO Regions had independently de-
veloped their own definitions before the 
2009–2010 influenza pandemic. These 
definitions were based on the case defi-
nition published by the Pan American 
Health Organization in 2005,20 which, 
in turn, was based on criteria set, as 
part of the integrated management of 
childhood illness strategy, for pneumo-
nia and severe pneumonia (Box 2). For 
children younger than five years, the 
strategy’s criteria for pneumonia were 
considered relatively nonspecific for 
radiographically confirmed pneumo-
nia. They were considered acceptable 
for use in the definition of SARI as 
they would capture both pneumonia 
caused by influenza and other respira-
tory diseases related to influenza, e.g. 
an exacerbation of asthma triggered 
by influenza and requiring hospitaliza-
tion.21 By 2011, the definitions devel-
oped by the integrated management of 
childhood illness strategy were already 
widely in use and could be adapted 
to cover hospital-based influenza, i.e. 
the severe end of the influenza-related 
disease spectrum, including those 
patients that did not have associated 
pneumonia. Severe influenza without 
pneumonia represents a substantial 
proportion of the burden posed by 
hospitalized influenza patients.21,22
During the WHO’s 2011 consulta-
tion, the consensus among countries 
conducting surveillance of severe influ-
enza was that it was desirable and most 
practical to have one definition of severe 
illness for all age groups.17 Although the 
integrated management of childhood 
illness strategy’s case definitions might 
have some use in this context, they are 
intended for clinical management in 
outpatient clinical settings23 and are 
generally not used by physicians in 
those hospitals where SARI surveillance 
is focused.
In 2011, in discussions involving 
the development of criteria for a case 
definition of SARI, concerns were raised 
about use of the pneumonia symptoms 
“shortness of breath” and “difficulty 
breathing”.17 Both of these symptoms are 
difficult to quantify and are often misin-
terpreted to include conditions such as 
nasal obstruction. Moreover, substantial 
shortness of breath only occurs as a late 
sign in the course of respiratory infec-
tions and inclusion of this symptom 
could therefore reduce the sensitivity of 
the definition.24
In the pneumonia case definition, 
the clinical sign “measured fever” was 
considered too restrictive for hospital-
ized patients, especially for capturing 
those patients who may have taken anti-
pyretics to reduce fever, patients who do 
not present with fever, as often seen in 
adults, and those who have progressive 
illness from ILI. “Measured fever” was 
therefore changed to “measured fever … 
or history of fever”. This change aimed to 
improve the sensitivity of the definition 
among hospitalized patients and allow 
more potential influenza cases to be 
identified for laboratory testing, and so 
allow the capture of a larger proportion 
of the disease burden due to influenza 
viruses (Box 3).
Lastly, as with the most recent ver-
sion of the ILI definition, “onset within 
the past 10 days” was added to the most 
recent version of the SARI definition 
Box 1. Revisiona of clinical case definition for influenza-like illness, 2011
Omit “sore throat”
Rationale: Studies have shown a lack of association between a sore throat and influenza in 
individuals with respiratory disease. Sore throat is also difficult to assess in infants.
Omit “absence of another diagnosis”
Rationale: The change prevents the exclusion of cases with underlying chronic conditions, such 
as asthma or chronic lung disease, which are risk factors for severe influenza.
Change “sudden onset of fever” to “acute respiratory illness”
Rationale: New term encompasses a broad, well-known syndrome and relates the definition to 
a clinically recognized condition.
Add a timeframe, of ten days from symptom onset
Rationale: Helps capture acute illness and distinguish new illness superimposed on old.
Temperature of measured fever changed from “> 38 °C” to “≥ 38 °C”
Rationale: Captures individuals with temperatures that, although above 38 °C, are recorded as 
38 °C by clinicians and record-keepers who round down such temperatures.
Result
“An acute respiratory illness with a measured temperature of ≥ 38 °C and cough, with onset 
within the past 10 days”.
a  Compared with corresponding definition published in 1999.9
Box 2. Criteria previously used in regional definitions of severe acute respiratory 
infection
Among individuals aged above five years, the criteria used were those for pneumonia in this 
age group, i.e. sudden onset of fever above 38°C, cough or sore throat, shortness of breath or 
difficulty breathing, and requiring hospitalization.
Among individuals aged between two months and five years, the criteria used were either 
those for pneumonia in this age group, i.e. cough or difficulty breathing and a breathing rate 
above 60, 50 and 40 breaths per minute for those younger than two months, between two and 
12 months and older than 12 months, respectively, or those for severe pneumonia in this age 
group, i.e. cough or difficulty breathing, requiring hospitalization and showing at least one of 
five danger signs.a
a  The five danger signs were: unable to drink or breastfeed; vomiting everything ingested; having 
convulsions; being lethargic or unconscious; and showing chest indrawing or stridor while calm.
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(Box 3). Although a period of seven days 
was originally considered,17 a review of 
available data indicated that patients 
with SARI that presented between seven 
and 10 days after symptom onset were 
no less likely to be laboratory-test-posi-
tive for influenza, as those that presented 
closer to symptom onset (E Dueger, 
United States Centers for Disease 
Control and Prevention, unpublished 
data, 2013; MT Olivera da Costa, Belo 
Horizonte Municipal Health Secretariat, 
unpublished data, 2013).24,25 Extending 
the period to include patients within 10 
days of symptom onset allowed more 
influenza cases to be captured, without 
sacrificing specificity. The proposed 
clinical case definition of SARI, among 
all age groups, therefore became “an 
acute respiratory illness with a history 
of fever or measured fever of ≥ 38 °C 
and cough, with onset within the past 10 
days, requiring hospitalization”. To sim-
plify the implementation process, the 
same criterion, i.e. “onset within the past 
10 days”, was subsequently used in the 
case definitions of both ILI and SARI.
Practical implications
Since the WHO’s recommendations 
for the revision of the case definition 
of ILI,17 several studies have examined 
the best predictors of influenza virus 
infections that are appropriate for all 
age groups. The results of these stud-
ies supported the use of the simplified 
criteria of “cough” and “fever” in, and 
the removal of “sore throat” from, the 
clinical case definition of such infec-
tions.26–30 When the performance of 
the 2011 WHO case definition of ILI 
was compared with that of three cor-
responding definitions, one developed 
by the European Centre for Disease 
Prevention and Control, one developed 
by the United States Centers for Dis-
ease Control and Prevention and one 
developed in Taiwan, China, the WHO 
definition was found to have the highest 
specificity.28,30
In a study conducted among hospi-
talized patients in rural India, addition 
of reported “history of fever” to a case 
definition of ILI that already included 
“measured fever”, improved sensitivity, 
but reduced specificity.29 Without “his-
tory of fever”, the definition gave poor 
sensitivity, particularly among patients 
younger than five years. Along with 
cough, measured and/or reported fever 
were considered to provide the best bal-
ance between sensitivity and specificity 
among the study population.29
In a Ghanaian study, performance 
of the 2011 WHO case definition of 
SARI was evaluated in both young and 
old hospitalized patients. In this study, 
98% of the influenza cases with SARI 
presented with cough and current fever 
and/or history of fever.31 The accuracy of 
influenza identification was investigated 
among hospitalized patients in Kenya 
using case definitions of both SARI 
and pneumonia.32 Compared with the 
pneumonia definition, the SARI case 
definition gave higher sensitivity and 
lower specificity when applied to pa-
tients younger than five years and it gave 
higher specificity when applied to older 
patients. Since, for influenza surveil-
lance, the performance of the pneumo-
nia definition appeared generally similar 
to that of the SARI definition, it was 
suggested that hospital-based influenza 
surveillance could be integrated within 
the existing platforms for pneumonia 
surveillance.32
As the separation of influenza 
from other respiratory virus infections 
remains a challenge, any attempt at in-
fluenza identification that is based on a 
so-called one-size-fits-all approach will 
have its shortcomings.33 This is espe-
cially true when estimating the burden 
posed by influenza in all age groups. 
Although fever has been shown to be the 
one of the most predictive symptoms of 
influenza, it occurs in many other com-
mon respiratory diseases, particularly 
among young children.28 By expanding 
the SARI case definition to include 
history of fever, more young children 
infected with non-influenza respira-
tory viruses may be mis-identified as 
cases of influenza. As young children 
infected with influenza viruses do not 
present with some of the symptoms that, 
in adults, are useful clinical predictors 
of such infection, the use of the latest 
case definition of SARI for influenza 
surveillance among such children needs 
to be very cautious.34 This is particularly 
true during the peak in the influenza 
season, which tends to coincide with a 
peak in the circulation of other respira-
tory viruses. For the detection of infec-
tions with influenza viruses in children 
younger than five years, it may be advis-
able to use a tailored case definition, e.g. 
one that uses a higher temperature cut-
off for fever28 or includes rhinorrhea or 
other additional respiratory symptoms35, 
to increase specificity.
The age-specific differences ob-
served in the distributions of influenza 
virus subtypes28 may be only partially re-
sponsible for the age-related differences 
observed in health-seeking behaviour, 
following infection with an influenza vi-
rus.36 Such variation and the issue of in-
fections with non-influenza respiratory 
viruses being confused with influenza, 
may lead to substantial sampling bias in 
attempts to follow influenza epidemiol-
ogy on a national scale. Infections with 
respiratory syncytial virus have been 
shown to decrease the performance of a 
WHO clinical case definition when that 
definition was used for influenza surveil-
lance.34 One aim of a global surveillance 
scheme for respiratory syncytial virus 
Box 3. Developmenta of a new case definition of severe acute respiratory infection, 2011
Drop use of separate criteria for pneumonia and severe pneumonia among children aged < 5 
years
Rationale: Use of a single SARI case definition for all age groups simplifies implementation. The 
IMCI case definitions represent a clinical management tool and not very suitable for surveillance.
Drop “shortness of breath” and “difficulty breathing”
Rationale: These symptoms are not sufficiently specific, do not add to the accuracy of the 
definition and are often misinterpreted.
Add “history of fever”
Rationale: This allows for the inclusion of cases that have taken antipyretics that could have 
reduced fever and those, such as many older adults and the chronically ill, that do not have 
fever when admitted.
Increase time frame between symptom onset and presentation from seven days to 10 days
Rationale: SARI cases that present between seven and 10 days after symptom onset appear no 
less likely to be laboratory-test-positive for influenza as those that present closer to symptom 
onset. Increasing the time frame to 10 days should therefore allow more cases to be captured, 
without markedly increasing the use of resources.
SARI: severe acute respiratory infection.
a  Compared with previous regional definitions based on the criteria used by the Integrated Management 
of Childhood Illness strategy (Box 2).
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that is being developed by WHO is 
to assess the potential adverse impact 
of the virus on existing ILI and SARI 
surveillance.37
The primary goal of influenza 
surveillance is not to capture every 
influenza case, but to follow patterns 
in transmission and disease burden 
and changes in the influenza viruses 
that are circulating. Although WHO 
recommends the use of the ILI and 
SARI case definitions that resulted 
from the 2011 consultations and were 
finalized in late 2011, it does not 
necessarily advise against the use of 
other definitions, so long as they are 
broader and do not screen out any 
individuals who would otherwise have 
been screened in. Now more than 
ever, the pandemic threat posed by 
novel respiratory viruses underscores 
the need for a robust global system of 
influenza surveillance, based on global 
case definitions. ■
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ملخص
مراجعة تعريفات احلالة من الناحية العالجية: املرض املشابه لألنفلونزا وعدوى اجلهاز التنفيس احلادة واحلرجة
جزء  العالجية  الناحية  من  للحاالت  دقيقة  تعريفات  صياغة  إن 
أسايس من اإلجراءات الفعالة ملراقبة الصحة العامة. وبالرغم من 
عىل  تقوم  أن  النظرية،  الناحية  من  جيب،  التعريفات  هذه  مثل  أن 
جمموعة منتقاة من املعايري التعريفية املوحدة والثابتة، فغالًبا ما حتتاج 
التي تستجد  املعلومات  املراجعة لكي تعكس  التعريفات إىل  تلك 
االختبارات  تشهدها  التي  والتطورات  هبا  املرتبطة  احلالة  بشأن 
املثالية للحاالت إىل املوازنة  التعريفات  التشخيصية. وحتتاج أيًضا 
بني احلساسية والنوعية بام يتفق مع االستخدام املزمع. وبعد تفيش 
فريوس األنفلونزا H1N1 يف الفرتة ما بني عامي 2009 و2010، 
بدأت منظمة الصحة العاملية يف تقديم املشاورة التقنية بشأن مراقبة 
حتسني  عىل  ذلك  شجع  وقد  العاملي.  املستوى  عىل  األنفلونزا 
بعبارة   - األنفلونزا  حالة  بتعريف  املرتبطة  والنوعية  احلساسية 
أعراض  جمموعة  إىل  يفتقر  التنفيس  اجلهاز  يصيب  مرض  أخرى، 
فريدة تعّرف املرض. وأدت إجراءات املراجعة إىل تعديل تعريف 
ذلك املرض املشابه لألنفلونزا، إذ شمل التعريف قائمة مبسطة من 
املعايري التي تبني أهنا األفضل للتنبؤ بعدوى األنفلونزا، ومل تقترص 
اإلجراءات  تلك  عن  أيًضا  نتج  بل  فحسب،  ذلك  عىل  النتائج 
عىل  القدرة  لتحسني  التعريف،  يف  وضوًحا  أكثر  لغة  استخدام 
التأويل. ولتحقيق الدقة يف رصد احلاالت احلرجة لألنفلونزا والتي 
حلالة  جديد  تعريف  وضع  أيًضا  تم  باملستشفى،  اإلقامة  تتطلب 
العدوى التنفسية احلادة واحلرجة جلميع الفئات العمرية. وتبني أن 
مزيًدا من احلاالت دون اإلخالل  بدقة  اجلديدة ترصد  التعريفات 
من  التمييز  عند  قائاًم  يزال  ال  التحدي  أن  من  وبالرغم  بالنوعية. 
اجلهاز  عدوى  أنواع  من  وغريها  األنفلونزا  بني  العالجية  الناحية 
توصلت  ملا  العاملي  االستخدام  يساعد  أن  املفرتض  من  التنفيس، 
إليه منظمة الصحة العاملية من تعريفات جديدة للحالة عىل حتديد 
االجتاهات العامة فيام يتعلق بخصائص فريوسات األنفلونزا وطرق 






















Révision de définitions de cas cliniques: syndrome de type grippal et infection aigüe sévère des voies respiratoires
La formulation de définitions précises de cas cliniques fait partie 
intégrante d’un processus efficace de surveillance de la santé publique. 
Alors que ces définitions devraient, dans l’idéal, s’appuyer sur un 
ensemble standardisé et fixe de critères de définition, elles nécessitent 
souvent une révision pour tenir compte des nouvelles connaissances 
relatives à la maladie concernée et des améliorations apportées aux 
tests diagnostiques. Pour être optimales, les définitions de cas doivent 
aussi établir un équilibre entre sensibilité et spécificité qui reflète leur 
utilisation aux fins prévues. À la suite de la pandémie de grippe H1N1 
de 2009-2010, l’Organisation mondiale de la Santé (OMS) a lancé une 
consultation technique sur la surveillance mondiale de la grippe. Cela 
a conduit à des améliorations concernant la sensibilité et la spécificité 
de la définition de cas pour la grippe – c’est-à-dire une maladie 
respiratoire dont seule la symptomatologie reste à définir. Le processus 
de révision n’a pas seulement modifié la définition du syndrome de type 
grippal pour inclure une liste simplifiée des critères le mieux à même 
de prédire une infection grippale, il a également permis de clarifier le 
langage utilisé dans la définition pour en améliorer l’interprétation. Par 
ailleurs, afin de tenir compte des cas sévères de grippe qui nécessitaient 
une hospitalisation, une nouvelle définition de cas a été introduite 
concernant l’infection aigüe sévère des voies respiratoires dans tous les 
groupes d’âge. Il a été constaté que les nouvelles définitions reflétaient 
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davantage de cas, sans pour autant compromettre la spécificité. S’il 
est vrai que la distinction clinique de la grippe des autres infections 
respiratoires continue de poser problème, l’utilisation mondiale des 
nouvelles définitions de cas de l’OMS devrait permettre de dégager des 
tendances mondiales concernant les caractéristiques et la transmission 
des virus grippaux ainsi que la charge de morbidité qui leur est associée.
Резюме
Пересмотр определений клинических случаев: гриппоподобное заболевание и тяжелая острая 
респираторная инфекция
Формулировка точных определений клинических случаев 
является неотъемлемой частью эффективного эпиднадзора. 
Хотя в идеале такие определения должны основываться на 
стандартизованном и фиксированном наборе определяющих 
критериев, они часто требуют пересмотра с учетом новых 
знаний об этих состояниях и улучшениях в диагностическом 
тестировании. Оптимальные определения случаев также 
должны иметь баланс чувствительности и специфичности, 
который отражает их целевое назначение. После пандемии 
гриппа H1N1 в 2009–2010 годах Всемирная организация 
здравоохранения (ВОЗ) инициировала техническую консультацию 
по глобальному эпиднадзору за гриппом. Это привело к 
улучшению чувствительности и специфичности определения 
для гриппа, то есть респираторного заболевания, которое не 
имеет однозначной определяющей симптоматики. Пересмотр 
привел не только к изменению определения гриппоподобного 
заболевания, включив в него упрощенный список критериев, 
показавших, что гриппозная инфекция является наиболее 
прогностической, но и для улучшения интерпретируемости 
был сделан более понятным язык, используемый для этого 
определения. Для выявления тяжелых случаев гриппа, требующих 
госпитализации, было разработано новое определение для 
тяжелой острой респираторной инфекции во всех возрастных 
группах. Было обнаружено, что новые определения охватывают 
больше случаев без ущерба для специфичности. Несмотря на 
сложности, которые все еще возникают при дифференциации 
гриппа от других респираторных инфекций, глобальное 
использование новых определений ВОЗ должно помочь выявить 
всеобщие тенденции в характеристиках и передаче вируса 
гриппа, а также в связанном с ними бремени болезней.
Resumen
Revisión de las definiciones de los casos clínicos: enfermedad similar a la gripe e infección respiratoria aguda grave
La elaboración de definiciones precisas de los casos clínicos es una 
parte fundamental de un proceso efectivo de la vigilancia de la salud 
pública. Aunque tales definiciones deberían, idealmente, estar basadas 
en una recopilación estandarizada y fija de criterios de definición, a 
menudo necesitan una revisión para reflejar el nuevo conocimiento de 
la enfermedad existente y las mejoras en las pruebas de diagnóstico. Las 
definiciones óptimas de los casos también deben tener un equilibrio 
entre sensibilidad y especificidad que refleje su uso previsto. Después 
de la pandemia de gripe H1N1 en 2009-2010, la Organización Mundial 
de la Salud (OMS) inició una consulta técnica para la vigilancia mundial 
de la gripe. Esto dio lugar a mejoras en la sensibilidad y la especificidad 
de las definiciones de los casos de gripe, es decir, una enfermedad 
respiratoria que carece de una sintomatología definitoria singular. El 
proceso de revisión no solo modificó la definición de las enfermedades 
similares a la gripe para incluir una lista simplificada de los criterios que 
demostraron ser más predictivos de la infección por gripe, sino que 
también aclaró el lenguaje utilizado para la definición, con el fin de 
mejorar su interpretación. Para englobar los casos graves de gripe que 
requirieron hospitalización, también se desarrolló una nueva definición 
de los casos de la infección respiratoria aguda grave en todos los grupos 
de edad. Se ha descubierto que las nuevas definiciones engloban más 
casos sin comprometer la especificidad. A pesar del desafío que todavía 
plantea la separación clínica de la gripe de otras infecciones respiratorias, 
el uso global de las nuevas definiciones de los casos de la OMS debería 
ayudar a determinar las tendencias mundiales en las características y 
transmisión de los virus de la gripe y la carga de la enfermedad asociada.
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